Metraipolis › archive › dc_11118bf118fe

Comparable Benefits in Heart Failure Hospitalization and Survival with Sacubitril/Valsartan Therapy in CRT Nonresponders and HFrEF Patients Without CRT… — Europe PMC PMID:40943860

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40943860
DOI
10.3390/jcm14176098
License (as archived)
solo-consultazione
Archived
2026-11-10T07:20:59.425Z
SHA-256 of the archived text
953c15d0110df0afb486308ee86334317a6903df939a384c30239a583763030c
Stable URL of this page
https://metraipolis.com/documento/dc_11118bf118fe

How to cite

Comparable Benefits in Heart Failure Hospitalization and Survival with Sacubitril/Valsartan Therapy in CRT Nonresponders and HFrEF Patients Without CRT… — Europe PMC PMID:40943860 — Europe PMC (en), https://europepmc.org/article/MED/40943860 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_11118bf118fe (Metraipolis archive dc_11118bf118fe, sha256 953c15d0110df0afb486308ee86334317a6903df939a384c30239a583763030c)
BibTeX
@misc{dc11118bf118fe,
  title = {Comparable Benefits in Heart Failure Hospitalization and Survival with Sacubitril/Valsartan Therapy in CRT Nonresponders and HFrEF Patients Without CRT… — Europe PMC PMID:40943860},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40943860},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_11118bf118fe; sha256 953c15d0110df0afb486308ee86334317a6903df939a384c30239a583763030c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40943860. Agents can read the archived copy with the MCP tool read_document.